Facts and Figures
  • Spondyloarthritis patients have a 7-9% higher risk for developing inflammatory bowel disease.
  • Tumor Necrosis Factor Inhibitors (TNFi or anti-TNF) drugs are known as biologic drugs. They are made from large live molecules.
  • Exercise is a recommended treatment option to help manage spondyloarthritis.
  • ASAS, the Assessment of SpondyloArthritis international Society, recommends membership in a patient organization as an additional treatment option.